REQUEST A DEMO
Total
USD $0.00
Search more companies

Afofarm ZAO (Russia)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full name: Afofarm ZAO Profile Updated: August 18, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Russian Download a sample report

Afofarm ZAO is an enterprise in Russia, with the main office in Dolgoprudnyi. The enterprise currently operates in the Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) sector. It was established on October 22, 2007. The total number of employees is currently 2 (2022). The company’s latest financial report indicates a net sales revenue increase of 16.19% in 2023. Its’ total assets recorded a growth of 8.26%. The net profit margin of Afofarm ZAO decreased by 38.47% in 2023.

Headquarters
Lihachevskii, 5B
Dolgoprudnyi; Moscow Oblast; Postal Code: 141701

Contact Details: Purchase the Afofarm ZAO report to view the information.

Website: http://aphobazolum.ru

Basic Information
Total Employees:
Purchase the Afofarm ZAO report to view the information.
Outstanding Shares:
Purchase the Afofarm ZAO report to view the information.
Registered Capital:
Purchase the Afofarm ZAO report to view the information.
Incorporation Date:
October 22, 2007
Key Executives
Purchase this report to view the information.
General Director
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Afofarm ZAO report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
16.19%
Total operating revenue
16.19%
Operating profit (EBIT)
15.98%
Net Profit (Loss) for the Period
-42.07%
Total assets
8.26%
Total equity
8.4%
Operating Profit Margin (ROS)
-0.18%
Net Profit Margin
-38.47%
Return on Equity (ROE)
-6.75%
Quick Ratio
3.8%
Cash Ratio
-0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?